A drug known on the street as “Special K” could be the newest innovation in anti-depression treatment. In a review article published in “Science” on Oct. 5, Ronald Duman and George Aghajanian, psychiatry professors at the Yale School of Medicine, brought together more than a decade of research on the drug ketamine and its potential »